Replies to post #377533 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Birdbrain Ideas]

Thanks Raf. I guess we can view it as a win if we didn't have a substantial loss in scripts.

[Whalatane]

Thx for the numbers Raf
Kiwi

[ChuckC111]

DO YOU THINK THAT AMARIN WILL BE ABLE TO DECELERATE THE GENERICS EROSION OF VASCEPA?
WHAT ARE THE CHANCES THAT SARISSA FORCES A SALE OF THE COMPANY?
DO YOU THINK THAT PFIZER WOULD BE THE LEADING CANDIDATE TO ACQUIRE AMARIN?
AS PER TIMING, I THINK THAT A CHINA APPROVAL ALONG WITH APPROVALS FROM SIX EUROPEAN COUNTRIES WOULD GIVE THE BUYER AN INCENTIVE.
CHEERS,
ANDREW

[rafunrafun]

Scripts for week ending May 13, 2022

Drug Industry TRx: -1.6% w/w; +9.4% y/y

Vascepa
TRx 66,309; -0.6% (-388) w/w; -21.8% y/y
NRx 30,912; +0.7% (+227) w/w; -18.7% y/y
Ref 35,397; -1.7% (-615) w/w; -24.2% y/y

Lovaza (Generic & Brand)
TRx 63,359; +0.4% (+238) w/w; +3.7% y/y
NRx 31,862; +0.7% (+219) w/w; +7.1% y/y
Ref 31,497; +0.1% (+20) w/w; +0.5% y/y

Generic Vascepa
TRx 37,743; +4.2% (+1,514) w/w; As % of total V: 36.3%
NRx 21,114; +3.4% (+700) w/w; As % of total V: 40.6%
Ref 16,629; +5.1% (+814) w/w; As % of total V: 32.0%

Generic Vascepa by Manufacturer
Hikma - TRx 9,892; (+1,526) w/w; Generic share 26.2%; Total V share 9.5%
Reddy - TRx 18,636; (+642) w/w; Generic share 49.4%; Total V share 17.9%
Apotex - TRx 9,214; (-657) w/w; Generic share 24.4%; Total V share 8.9%

Vascepa + Generic Vascepa
TRx 104,052; +1.1% (+1,126) w/w; +10.0% y/y
NRx 52,026; +1.8% (+927) w/w; +19.7% y/y
Ref 52,027; +0.4% (+199) w/w; +1.8% y/y